Alignment Healthcare, Inc. (ALHC)

From the record

Alignment Healthcare, Inc.'s filings since 2020 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Alignment Healthcare, Inc.'s 7 filed years say what it did: revenue went from $757 million in fiscal 2019 to $3.9 billion in fiscal 2025, up 31.7% a year; it rose in 6 of 6 years; it never fell from a peak; net income was positive in 0 of 7 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Alignment Healthcare, Inc.'s diluted share count grew about 3.0% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 78 sales (47 under scheduled 10b5-1 plans) and 1 purchase of their own stock on the open market in the year to 2026-11-12, buying about $198 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Alignment Healthcare, Inc. lost about 0 cents for every dollar of shareholders' money. Leverage: it owed about 83 cents per dollar of assets, and net share issuance: its share count grew 3.8% over the year (the filed statements).

From the record

Alignment Healthcare, Inc.'s standing among 10 graded names in its industry family: revenue of $3.9 billion in fiscal 2025 ranks in the bottom 25% by size; a net margin of 0% ranks in the bottom 35%; revenue growth of 40.1% a year over the last 3 filed years ranks in the top 15% (its annual reports).

From the record

Alignment Healthcare, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Kao, John E (Chief Executive Officer, as filed), filing under that title since 2021-03-26, 5.6 years (top 28% of its family); the 19 officers and directors filing in the last fifteen months have been on the record a median of 4.9 years (top 50%); 4 officer or director changes were reported on Form 8-K since 2023-11-13, against the 19 people in charge now (top 15%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Alignment Healthcare, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $578 million against debt of $323 million leaves 23.9% of its assets as net cash, top 15% of its family; cash from operations less capital spending is 2.9% of revenue (top 45%) (its annual report).

From the record

Alignment Healthcare, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 40.1% a year over the last three filed years against 31.7% over all 7, speeding up (top 5% of its family); the newest year grew 46.1% (top 5%); capital spending grew 4% a year (top 35%) (its annual reports). Alignment Healthcare, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

Alignment Healthcare, Inc.'s newest year against its own record: revenue of $3.9 billion in fiscal 2025 came in 6.4% above the $3.7 billion its prior three years' pace pointed to (top 25% of its family); net income of $724 thousand against a prior three-year average of $142 million (top 15%); a net margin of -0% against -7.8% before (top 15%) (its annual reports).